Skip to content

Clinical trials

Phase 2 Movement Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Movement Disorders Phase: Phase 2 Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20101
20111
20122
20141
20161
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Sun Pharmaceutical Industries, Inc.3
Western University, Canada2
Bial R&D Investments, S.A.1
Praxis Precision Medicines1
Ron Postuma1
Vima Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Movement Disorders12
Parkinson Disease7
Parkinsonian Disorders6
Dyskinesias4
Essential Tremor4
Central Nervous System Diseases3
Neurodegenerative Diseases3
Basal Ganglia Diseases2
Brain Diseases2
Nervous System Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.